Non-Current Assets
Deferred Tax Assets
AbbVie Deferred Tax Assets decreased by 94.3% to $137M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 94.7%, from $2.58B to $137M. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets shows a downward trend with a -8.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryOther
SignalHigher is better
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026May 8, 2026
How to read this metric
An increase suggests potential future tax savings, while a decrease may indicate the utilization of these assets or valuation allowances.
Detailed definition
These are assets on the balance sheet that represent future tax savings resulting from temporary differences between acc...
Peer comparison
Standard accounting item for large corporations with complex tax structures and international operations.
Metric ID:
deferred_tax_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.66B | $3.6B | $3.01B | $2.83B | $2.26B | $1.97B | $2.19B | $2.11B | $2.12B | $2.04B | $1.95B | $2.72B | $2.73B | $2.75B | $2.58B | $2.58B | $2.55B | $2.48B | $2.39B | $137M |
| QoQ Change | — | -1.6% | -16.5% | -5.9% | -20.3% | -12.5% | +11.1% | -3.7% | +0.7% | -3.8% | -4.5% | +39.4% | +0.1% | +0.8% | -6.2% | +0.1% | -1.1% | -2.9% | -3.7% | -94.3% |
| YoY Change | — | — | — | — | -38.4% | -45.3% | -27.2% | -25.5% | -5.8% | +3.7% | -10.9% | +29.0% | +28.3% | +34.5% | +32.1% | -5.1% | -6.3% | -9.8% | -7.4% | -94.7% |
Range$137M – $3.66B
CAGR-49.9%
Avg YoY Growth-9.3%
Median YoY Growth-6.8%
Current Streak4 quarters decline
Deferred Tax Assets at Other Companies
Frequently Asked Questions
- What is AbbVie's deferred tax assets?
- AbbVie (ABBV) reported deferred tax assets of $137M in Q1 2026.
- How has AbbVie's deferred tax assets changed year-over-year?
- AbbVie's deferred tax assets decreased by 94.7% year-over-year, from $2.58B to $137M.
- What is the long-term trend for AbbVie's deferred tax assets?
- Over 5 years (2020 to 2025), AbbVie's deferred tax assets has grown at a -8.1% compound annual growth rate (CAGR), from $3.65B to $2.39B.
- What does deferred tax assets mean?
- Future tax benefits that the company expects to realize.